The genetic skin disease psoriasis has been examined as a model system that may provide an understanding of the control of normal epidermal specialization (differentiation) and the perturbed regulatory processes in proliferatioe diseases . The excessive glycogen accwnulation, increased proliferation and decreased tissue specialization characteristic of psoriasis involve cellular processes that have been shown to be regulated by cyclic AMP in other cells and tissues .
It has also been suggested that cyclic GMP is a cellular effector that may be involved in promoting cell proliferation and other events that oppose those believed to be mediated by cyclic AMP .
It was postulated, therefore, that the epidermis of the psoriasis lesion might exhibit an imbalance in the cellular concentrations of these two cyclic nucleotides . In this study the levels of cyclic AMP were measured in the involved epidermis (IE) and uninvolved epidermis (UE) from 25 psoriasis patients . The concentrations of cyclic AMP were found as reported previously using a different analytical procedure, to be significantly lower in IE based on protein and DNA . A comparison of the levels of cyclic . GMP in IE versus UE of 12 other psoriasis patients showed the levels of this cyclic nucleotide to be significantly increased in IE based on protein, DNA and wet weight . We suggest that this imbalance in the ratio of these two cyclic nucleotides may have pathophysiological relevance to the initiation and/or the maintenance of the psoriasis lesion . Taking the foregoing into account our original postulate was that the abnormalities in the lesions of common proliferative skin diseases, as exemplified by psoriasis, might derive from or be associated with decreased levels of cyclic AMP in IE versus UE (6) .
This hypothesis was first tested by determining the levels of cyclic AMP in IE versus UE of epidermis from psoriasis patients using the analytical procedure for cyclic AMP determination described by Brooker, et al (7) . The results of these studies showed that cyclic AMP concentrations were lower in IE than UE ; the decreases were determined to be highly significant when calculated on the basis of either wet weight, DNA or protein content of the sample (8) .
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To further critically test our postulate a second study was initiated in which we sought to confirm these previously detected decreases by using a second cyclic AMP assay based upon a dif ferent analytical prinicple (9) . During this second study we became aware of the hypothesis of Goldberg, et al (10) that guanosine 3',5'-monophosphate (cyclic GMP) might be associated with promoting a number of cellular events that are antagonistic to those thought to be mediated by cyclic AMP . Hadden, et al (11) reported that mitogen induced lymphocyte proliferation was associated with strikingly increased cellular levels of cyclic GMP and proposed that cyclic GMP may be an intracellular effector involved in promoting the proliferatioe process . Accordingly, our study was extended in order to determine whether an imbalance might exist in the levels of both cyclic nucleotides in IE versus UE of psoriasis .
The purpose of the present communication is to present the results of these studies which demonstrate that cyclic AMP levels are significantly decreased and cyclic GMP levels significantly increased in IE versus UE of psoriasis patients . A scheme for epidermal growth control is proposed modeled after Goldberg, et al (10) and Hadden, et al (11) which derives from the "Yin-Yang" or "dualism" hypothesis of biological regulation .
Patient Selection

Materials and Methods
After obtaining informed consent, biopsies were taken from patients with well-developed lesions of large plaque psoriasis .
The psoriasis patients selected had not used antipsoriasis Criteria for histologic acceptability have described in detail (8 (17) and subsequently by thin layer chromatography (TLC) on silica gel (16) . Portions of the eluates from the TLC purification were used to estimate recovery, noncyclic GMP (i .e ., non-phosphodiesterase hydrolyzable) reactive material, and cyclic GMP content.
The latter two measurements were performed in triplicate .
er imenta l and Statistical Design
In the absence of a stable denominator the data have been expressed in terms of wet weight, protein and DNA content of the Tables 1 and 2 were performed. on an IBM 360/67
computer . All the data are expressed as mean (X) + 1 standard error (SE) of the mean .
Results Table 1 shows that the concentration of cyclic AMP in IE is less than that found in UE . The absolute percent decrease differs depending upon the manner used to express the data ; decreases of 43~, 36~or 17~were calculated when the amount of cyclic AMP was expressed on the basis of protein, ANA or wet weight, respectively.
The differences between the means used to calculate the percents are highly significant (p< .005) when protein and DNA are the These data indicate that the mean cyclic AMP concentration was lower in IE versus UE of psoriasis . Nevertheless, it should be pointed out that although 22 of the 25 patients studied exhibited lower cyclic AMP levels in IE than UE, the levels of 3 patients (i .e ., based on protein or DNA) were 20$ higher in IE specimens . With wet weight as a denominator, 9 patients had cyclic AMP levels 28$ higher in IE than in UE . However, as shown in the materials and methods section, the concentration of metabolites in IE versus UE is probably most reliably determined when based on DNA content rather than on wet weight of the tissue sample . Table 2 shows that the concentration of cyclic GMP in IE is greater than in UE . The absolute percent increase again depends on the denominator used to express the data ; calculated by the 3 different methods increases of 106$, 93$ or 112$ were obtained using protein, DNA or wet weight, respectively . The differences between the means used to calculate the percents are highly significant (p< .005) in terms of DNA and wet weight . When the denominator is protein the 106$ increase has moderate significance statistically (p< .02) .
Although the mean cyclic GMP level found in the 12 psoriasis patients was higher in IE than in UE, the cyclic GMP level of IE in one patient was lower than that of UE in terms of DNA and wet weight, the only two methods used to determine the concentration of cyclic GMP in the epidermis of this and two other patients .
Discussion
The results reported here in conjunction with previously reported data (8) strongly suggest that there is an imbalance in the levels of cyclic AMP and cyclic GMP in the involved epidermis of Cyclic GMP, Cyclic AMP and Psoriasis Vol . 13, No. 6 (Table 1 ) and upon previous work where a significant decrease (p<0 .001) was found using any one of the 3 denominators (8) .
The IE of psoriasis shows significant increases in the cellular levels of cyclic GMP (Table 2) 
